Ottobock SE & Co. KGaA (OBOCY)

Market Cap	3.36B -35.3%
Revenue (ttm)	1.98B +5.5%
Net Income	146.92M +122.1%
EPS	0.45 +118.7%
Shares Out	n/a
PE Ratio	27.62
Forward PE	14.11
Dividend	0.23 (1.80%)
Ex-Dividend Date	May 28, 2026

Volume	200
Open	12.55
Previous Close	15.20
Day's Range	12.55 - 12.55
52-Week Range	12.55 - 15.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Ottobock SE & Co. KGaA

Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company is involved in identification, development, manufacturing, sales, and marketing of prosthetics, neuro-orthotics, and digital solutions; prostheses for the upper and lower extremities; mechanical prostheses and technologically sophistic...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1919
• Employees: 9,406
• Stock Exchange: OTCMKTS
• Ticker Symbol: OBOCY

Financial Performance

In 2025, Ottobock SE & Co. KGaA's revenue was 1.68 billion, an increase of 4.69% compared to the previous year's 1.60 billion. Earnings were 90.20 million, an increase of 198.68%.

Financial numbers in EUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 9, 2026

Data Sources Report a data error